Skip to main content

Mingyi Xie

NIH Rank #11632
  • R01 Holder
  • Early Career
  • Diverse Portfolio

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 10892809Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Biochemistry

NIH Funding · FY2024

Linked Award Amount
$1.2M
Full award amounts, FY2024
Award Records
6
Records listing this PI
Award-Linked Rank
#11,632
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Mingyi Xie. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2024 award records by amount

NIH award records listing Mingyi Xie as a PI. Multi-PI records show the full award amount for context.

  • 5R01CA282812-02R01
    Exploring microRNA degradation in T-cell acute lymphoblastic leukemia
    $478.7K
    award amount
  • 5R35GM128753-07R35
    Molecular mechanisms for regulating microRNA levels in metazoans
    $411.8K
    award amount
  • 1R21CA287107-01R21
    The molecular basis of 7SK RNA methylation in non-small cell lung cancer
    $178.2K
    award amount
  • 3R01CA282812-02S1R01
    Exploring microRNA degradation in T-cell acute lymphoblastic leukemia
    $81.6K
    award amount
  • 3R21CA287107-01S1R21
    The molecular basis of 7SK RNA methylation in non-small cell lung cancer
    $52.6K
    award amount
  • 3R01CA282812-01S1R01
    Exploring microRNA degradation in T-cell acute lymphoblastic leukemia
    $26.5K
    award amount

Award organization

Organizations that administered FY2024 awards listing Mingyi Xie as a PI.

FY2024 award administered by University of Florida (FL).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    University of Florida
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2025
    $2M Cumulative Funding
  5. 2025
    R01 Grant Holder

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Mingyi Xie.